2023 Q2 Form 10-Q Financial Statement

#000137763023000073 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $14.80M $34.90M $91.70M
YoY Change -77.94% -2.79% 44.41%
Cost Of Revenue $5.000M $5.700M $30.00M
YoY Change -39.76% 21.28% -0.99%
Gross Profit $9.800M $29.20M $61.70M
YoY Change -83.33% -6.41% 85.84%
Gross Profit Margin 66.22% 83.67% 67.28%
Selling, General & Admin $13.60M $30.30M $25.90M
YoY Change -32.34% 52.26% 56.97%
% of Gross Profit 138.78% 103.77% 41.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.100M $7.500M $7.700M
YoY Change -85.9% -7.41% -11.49%
% of Gross Profit 11.22% 25.68% 12.48%
Operating Expenses $14.70M $30.30M $33.60M
YoY Change -26.87% 52.26% 33.33%
Operating Profit -$4.900M -$30.60M $28.10M
YoY Change -187.5% 36.0% 251.25%
Interest Expense -$3.100M -$24.00M -$22.40M
YoY Change -84.73% 39.53% 34.94%
% of Operating Profit -79.72%
Other Income/Expense, Net -$400.0K -$23.40M $400.0K
YoY Change -97.18% -0.43% 300.0%
Pretax Income $545.3M -$54.00M $10.10M
YoY Change -6440.7% 17.39% 152.5%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $545.3M -$45.50M $6.100M
YoY Change -78000.0% 80.56% -29.07%
Net Earnings / Revenue 3684.46% -130.37% 6.65%
Basic Earnings Per Share $3.13 -$0.31
Diluted Earnings Per Share $3.13 -$0.31 $0.07
COMMON SHARES
Basic Shares Outstanding 174.1M shares 174.1M shares 82.00M shares
Diluted Shares Outstanding 174.1M shares 145.5M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.50M $69.70M $62.40M
YoY Change -77.52% -38.91% -38.52%
Cash & Equivalents $15.50M $69.00M $61.70M
Short-Term Investments $1.000M $700.0K $700.0K
Other Short-Term Assets $7.100M $12.80M $7.900M
YoY Change 33.96% 91.04% 102.56%
Inventory
Prepaid Expenses
Receivables $200.0K $39.20M $92.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $23.80M $121.7M $164.4M
YoY Change -83.27% -25.7% 3.79%
LONG-TERM ASSETS
Property, Plant & Equipment $16.90M $12.20M $13.00M
YoY Change 25.19% -14.08% -38.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $19.60M $1.300M $1.200M
YoY Change 1052.94% -27.78% -33.33%
Other Assets -$16.90M $22.10M $23.80M
YoY Change -174.45% -4.74% -5.18%
Total Long-Term Assets $19.60M $618.5M $628.0M
YoY Change -96.97% -5.97% -4.7%
TOTAL ASSETS
Total Short-Term Assets $23.80M $121.7M $164.4M
Total Long-Term Assets $19.60M $618.5M $628.0M
Total Assets $43.40M $740.2M $792.4M
YoY Change -94.51% -9.91% -3.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.400M $24.00M $25.00M
YoY Change -85.8% 83.21% 53.37%
Accrued Expenses $2.500M $26.80M $17.80M
YoY Change -78.45% 106.15% 32.84%
Deferred Revenue $3.800M $9.200M $10.20M
YoY Change -55.29% -6.12% -32.0%
Short-Term Debt $0.00 $1.121B $1.121B
YoY Change -100.0% 34928.13% 34934.38%
Long-Term Debt Due $0.00 $1.121B $1.121B
YoY Change -100.0% 34928.13% 34934.38%
Total Short-Term Liabilities $9.800M $1.205B $1.203B
YoY Change -96.5% 1988.04% 1623.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $52.90M $17.40M $18.00M
YoY Change 175.52% -12.12% -11.76%
Total Long-Term Liabilities $52.90M $67.20M $53.30M
YoY Change -94.38% -94.33% -95.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.800M $1.205B $1.203B
Total Long-Term Liabilities $52.90M $67.20M $53.30M
Total Liabilities $62.70M $1.272B $1.256B
YoY Change -94.87% 2.33% 4.62%
SHAREHOLDERS EQUITY
Retained Earnings $111.3M -$415.9M -$370.4M
YoY Change -130.5% 15.08% 11.57%
Common Stock $1.700M $1.700M $1.300M
YoY Change 112.5% 112.5% 62.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.30M -$531.8M -$515.3M
YoY Change
Total Liabilities & Shareholders Equity $43.40M $740.2M $792.4M
YoY Change -94.51% -9.91% -3.06%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $545.3M -$45.50M $6.100M
YoY Change -78000.0% 80.56% -29.07%
Depreciation, Depletion And Amortization $1.100M $7.500M $7.700M
YoY Change -85.9% -7.41% -11.49%
Cash From Operating Activities -$5.900M $10.40M -$10.60M
YoY Change -64.88% -144.07% 292.59%
INVESTING ACTIVITIES
Capital Expenditures $100.0K $1.000M $900.0K
YoY Change -112.5% 42.86% -150.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $300.0K $2.500M
YoY Change
Cash From Investing Activities -$100.0K -$700.0K $1.600M
YoY Change -87.5% 0.0% -188.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -49.60M -$2.400M -700.0K
YoY Change 114.72% -106.5% -84.09%
NET CHANGE
Cash From Operating Activities -5.900M $10.40M -10.60M
Cash From Investing Activities -100.0K -$700.0K 1.600M
Cash From Financing Activities -49.60M -$2.400M -700.0K
Net Change In Cash -55.60M $7.300M -9.700M
YoY Change 36.61% -42.06% 8.99%
FREE CASH FLOW
Cash From Operating Activities -$5.900M $10.40M -$10.60M
Capital Expenditures $100.0K $1.000M $900.0K
Free Cash Flow -$6.000M $9.400M -$11.50M
YoY Change -62.5% -138.68% 1177.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001377630
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q1 ncminc Noncancelable Long Term Contracts
NoncancelableLongTermContracts
0 usd
CY2023Q1 ncminc Length Of On Screen Advertising Time To Satisfy Agreement Obligations
LengthOfOnScreenAdvertisingTimeToSatisfyAgreementObligations
PT30S
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-30
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-33296
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
NATIONAL CINEMEDIA, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5665602
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6300 S. Syracuse Way, Suite 300
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Centennial
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
CY2023Q1 dei City Area Code
CityAreaCode
303
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
792-3600
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
NCMI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
174059774 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69000000.0 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61700000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
2100000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
2100000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
700000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
700000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1700000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1700000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39200000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92000000.0 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10700000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7900000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
121700000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
164400000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55800000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
54800000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12200000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13000000.0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
276400000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
270200000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
580900000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
586700000 usd
CY2023Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1000000.0 usd
CY2022Q4 us-gaap Other Investments
OtherInvestments
900000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
300000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
300000 usd
CY2023Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
2000000.0 usd
CY2022Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
3300000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22100000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23800000 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
618500000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
628000000.0 usd
CY2023Q1 us-gaap Assets
Assets
740200000 usd
CY2022Q4 us-gaap Assets
Assets
792400000 usd
CY2023Q1 ncminc Due To Founding Members Current
DueToFoundingMembersCurrent
15300000 usd
CY2022Q4 ncminc Due To Founding Members Current
DueToFoundingMembersCurrent
18200000 usd
CY2023Q1 ncminc Payable To Founding Members Under Tax Sharing Agreement Current
PayableToFoundingMembersUnderTaxSharingAgreementCurrent
300000 usd
CY2022Q4 ncminc Payable To Founding Members Under Tax Sharing Agreement Current
PayableToFoundingMembersUnderTaxSharingAgreementCurrent
300000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26800000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17800000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6000000.0 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8300000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
24000000.0 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25000000.0 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9200000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10200000 usd
CY2023Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
7300000 usd
CY2022Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
7900000 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
1120900000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1121100000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2300000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2200000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1204800000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1203100000 usd
CY2023Q1 ncminc Payable To Founding Members Under Tax Sharing Agreement Noncurrent
PayableToFoundingMembersUnderTaxSharingAgreementNoncurrent
49800000 usd
CY2022Q4 ncminc Payable To Founding Members Under Tax Sharing Agreement Noncurrent
PayableToFoundingMembersUnderTaxSharingAgreementNoncurrent
35300000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17400000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000000.0 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
67200000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
53300000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1272000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1256400000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
260000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
260000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174054114 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128402636 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1700000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1300000 usd
CY2023Q1 ncminc Additional Paid In Capital And Accumulated Deficit Common Stock
AdditionalPaidInCapitalAndAccumulatedDeficitCommonStock
-117600000 usd
CY2022Q4 ncminc Additional Paid In Capital And Accumulated Deficit Common Stock
AdditionalPaidInCapitalAndAccumulatedDeficitCommonStock
-146200000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-415900000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-370400000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-531800000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-515300000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
0 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
51300000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-531800000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-464000000.0 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
740200000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
792400000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34900000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35900000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5700000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4700000 usd
CY2023Q1 ncminc Network Costs
NetworkCosts
2400000 usd
CY2022Q1 ncminc Network Costs
NetworkCosts
2000000.0 usd
CY2023Q1 ncminc Theater Access Fees
TheaterAccessFees
19600000 usd
CY2022Q1 ncminc Theater Access Fees
TheaterAccessFees
17900000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9500000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10200000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20800000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9700000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5800000 usd
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
1300000 usd
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2000000.0 usd
CY2023Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
6200000 usd
CY2022Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
6100000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
65500000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
58400000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-30600000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22500000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
24000000.0 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
17200000 usd
CY2023Q1 ncminc Gain Loss On Re Measurement Of Payable To Founding Members Under Tax Sharing Agreement
GainLossOnReMeasurementOfPayableToFoundingMembersUnderTaxSharingAgreement
600000 usd
CY2022Q1 ncminc Gain Loss On Re Measurement Of Payable To Founding Members Under Tax Sharing Agreement
GainLossOnReMeasurementOfPayableToFoundingMembersUnderTaxSharingAgreement
-6400000 usd
CY2023Q1 ncminc Gain On Sale Of Asset
GainOnSaleOfAsset
-300000 usd
CY2022Q1 ncminc Gain On Sale Of Asset
GainOnSaleOfAsset
0 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23400000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23500000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54000000.0 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46000000.0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-54000000.0 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-46000000.0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8500000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-20800000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-45500000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25200000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45500000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25200000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145507981 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81040652 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145507981 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81040652 shares
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-54000000.0 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-46000000.0 usd
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
1300000 usd
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2000000.0 usd
CY2023Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
6200000 usd
CY2022Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
6100000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1500000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1400000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5800000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2700000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2200000 usd
CY2023Q1 ncminc Gain On Sale Of Asset
GainOnSaleOfAsset
-300000 usd
CY2022Q1 ncminc Gain On Sale Of Asset
GainOnSaleOfAsset
0 usd
CY2023Q1 ncminc Non Cash Gain Loss On Re Measurement Of Payable To Founding Members Under Tax Sharing Agreement
NonCashGainLossOnReMeasurementOfPayableToFoundingMembersUnderTaxSharingAgreement
600000 usd
CY2022Q1 ncminc Non Cash Gain Loss On Re Measurement Of Payable To Founding Members Under Tax Sharing Agreement
NonCashGainLossOnReMeasurementOfPayableToFoundingMembersUnderTaxSharingAgreement
-6400000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
100000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
100000 usd
CY2023Q1 ncminc Proceeds From Integration And Other Encumbered Theater Payments Made By Affiliates
ProceedsFromIntegrationAndOtherEncumberedTheaterPaymentsMadeByAffiliates
3900000 usd
CY2022Q1 ncminc Proceeds From Integration And Other Encumbered Theater Payments Made By Affiliates
ProceedsFromIntegrationAndOtherEncumberedTheaterPaymentsMadeByAffiliates
1200000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
200000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
200000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-52700000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10000000.0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6400000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4100000 usd
CY2023Q1 ncminc Increase Decrease In Due To Founding Members Current
IncreaseDecreaseInDueToFoundingMembersCurrent
-3500000 usd
CY2022Q1 ncminc Increase Decrease In Due To Founding Members Current
IncreaseDecreaseInDueToFoundingMembersCurrent
-1600000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1000000.0 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5200000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
5000000.0 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1500000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10400000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23600000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000000.0 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
700000 usd
CY2023Q1 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
300000 usd
CY2022Q1 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-700000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-700000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
400000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4500000 usd
CY2023Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
0 usd
CY2022Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
50000000.0 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
800000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1600000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1200000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6800000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
200000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2400000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36900000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7300000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63800000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71100000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113800000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
10400000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
200000 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 usd
CY2023Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
10300000 usd
CY2022Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 usd
CY2023Q1 ncminc Increase Decrease In Dividends Not Requiring Cash
IncreaseDecreaseInDividendsNotRequiringCash
0 usd
CY2022Q1 ncminc Increase Decrease In Dividends Not Requiring Cash
IncreaseDecreaseInDividendsNotRequiringCash
100000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
12200000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
15600000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-383500000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
10400000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
600000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-46000000.0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-100000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1400000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4200000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-421400000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-464000000.0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-15500000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10300000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
43690797 shares
CY2023Q1 ncminc Adjustments To Additional Paid In Capital Investment In Subsidiary
AdjustmentsToAdditionalPaidInCapitalInvestmentInSubsidiary
-10300000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-54000000.0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1600000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-531800000 usd
ncminc A2019 Esa Amendment Extension Period
A2019ESAAmendmentExtensionPeriod
P4Y
CY2023Q1 ncminc Agreement With Founding Members Remaining Term
AgreementWithFoundingMembersRemainingTerm
P16Y6M
CY2023Q1 ncminc Membership Units Conversion Ratio
MembershipUnitsConversionRatio
1
CY2023Q1 ncminc Bankruptcy Proceedings Case Number
BankruptcyProceedingsCaseNumber
Case No. 23-90291
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to the reserve for uncollectible accounts receivable, share-based compensation, income taxes, intangible assets and forecasts utilized to evaluate the Company’s ability to continue as a going concern. Actual results could differ from estimates.</span>
CY2022Q4 ncminc Customer With Revenue In Excess Of Ten Percent Of Accounts Receivable
CustomerWithRevenueInExcessOfTenPercentOfAccountsReceivable
1
CY2022Q4 ncminc Customer Percentage Of Accounts Receivable
CustomerPercentageOfAccountsReceivable
0.130
CY2022Q1 ncminc Customer With Revenue In Excess Of Ten Percent Of Total Revenue
CustomerWithRevenueInExcessOfTenPercentOfTotalRevenue
1
CY2022Q1 ncminc Customer With Revenue In Excess Of Ten Percent Of Total Revenue
CustomerWithRevenueInExcessOfTenPercentOfTotalRevenue
1
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0.0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5800000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
2044313 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
855753 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-45500000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25200000 usd
CY2023Q1 ncminc Consolidation Lessthan Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity For Purchase Of Intangible Asset
ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityForPurchaseOfIntangibleAsset
0 usd
CY2022Q1 ncminc Consolidation Lessthan Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity For Purchase Of Intangible Asset
ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityForPurchaseOfIntangibleAsset
4900000 usd
CY2023Q1 ncminc Consolidation Lessthan Wholly Owned Subsidiary Parent Ownership Interest Changes Income Tax And Other Impacts Of Subsidiary Ownership Change
ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIncomeTaxAndOtherImpactsOfSubsidiaryOwnershipChange
27500000 usd
CY2022Q1 ncminc Consolidation Lessthan Wholly Owned Subsidiary Parent Ownership Interest Changes Income Tax And Other Impacts Of Subsidiary Ownership Change
ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIncomeTaxAndOtherImpactsOfSubsidiaryOwnershipChange
-1700000 usd
CY2023Q1 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-18400000 usd
CY2022Q1 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-22000000.0 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34900000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35900000 usd
CY2023Q1 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
5000000.0 usd
CY2023Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3500000 usd
CY2022Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3900000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-45500000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25200000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145507981 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81040652 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145507981 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81040652 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023Q1 ncminc Percentage Of Cash Savings Related To Taxes
PercentageOfCashSavingsRelatedToTaxes
0.90
CY2023Q1 ncminc Related Party Tra Payment Cinemark
RelatedPartyTRAPaymentCinemark
0.0 usd
CY2023Q1 ncminc Related Party Tra Payment Regal
RelatedPartyTRAPaymentRegal
0.0 usd
CY2023Q1 ncminc Negative Distribution Madeto Limited Liability Company Member Cash Distributions Deferred
NegativeDistributionMadetoLimitedLiabilityCompanyMemberCashDistributionsDeferred
31.6 million
CY2023Q1 ncminc Theater Access Fees Net Of Beverage Revenues And Other Encumbered Theaters Payments
TheaterAccessFeesNetOfBeverageRevenuesAndOtherEncumberedTheatersPayments
13800000 usd
CY2023Q1 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
-13800000 usd
CY2022Q4 ncminc Theater Access Fees Net Of Beverage Revenues And Other Encumbered Theaters Payments
TheaterAccessFeesNetOfBeverageRevenuesAndOtherEncumberedTheatersPayments
15200000 usd
CY2022Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
-15200000 usd
CY2023Q1 ncminc Acjv Cash Distributions
ACJVCashDistributions
0 usd
CY2022Q1 ncminc Acjv Cash Distributions
ACJVCashDistributions
100000 usd
CY2021Q1 ncminc Term Loan Second Tranche Net
TermLoanSecondTrancheNet
43000000.0 usd
CY2023Q1 ncminc Outstanding Credit Facility Waiver Limit
OutstandingCreditFacilityWaiverLimit
39000000 usd
CY2023Q1 ncminc Aggregate Remainingof Principal Notes2028
AggregateRemainingofPrincipalNotes2028
0.65
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2023Q1 ncminc Deferred Income Tax Expense Net Of Valuation Allowance
DeferredIncomeTaxExpenseNetOfValuationAllowance
0.0 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16400000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2300000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17400000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
900000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
800000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
100000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
200000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
1000000.0 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
1000000.0 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
900000 usd
ncminc Amount Increase In Payment Per Theater Patron
AmountIncreaseInPaymentPerTheaterPatron
0.052 usd
CY2027Q4 ncminc Amount Increase In Payment Per Theater Patron
AmountIncreaseInPaymentPerTheaterPatron
0.08 usd
CY2019Q4 ncminc Platinum Spot Revenue Percentage
PlatinumSpotRevenuePercentage
0.25
CY2023Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
134300000 usd
CY2023Q1 ncminc Guarantor Obligations Maximum Exposure Undiscounted Additional Amount Accrued
GuarantorObligationsMaximumExposureUndiscountedAdditionalAmountAccrued
300000 usd
CY2022Q4 ncminc Guarantor Obligations Maximum Exposure Undiscounted Additional Amount Accrued
GuarantorObligationsMaximumExposureUndiscountedAdditionalAmountAccrued
400000 usd
CY2023Q1 us-gaap Cost Method Investments
CostMethodInvestments
100000 usd
CY2022Q4 us-gaap Cost Method Investments
CostMethodInvestments
100000 usd
CY2023Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1000000.0 usd
CY2022Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
900000 usd
CY2023Q1 ncminc Impairment On Investment
ImpairmentOnInvestment
0.0 usd
CY2022Q1 ncminc Impairment On Investment
ImpairmentOnInvestment
100000 usd
CY2023Q1 ncminc Impairment On Investment Remaining Balance
ImpairmentOnInvestmentRemainingBalance
0.0 usd
CY2023Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
800000 usd
CY2022Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
200000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1000000.0 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1000000.0 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1000000.0 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1000000.0 usd
CY2023Q1 ncminc Bankruptcy Proceedings Case Number
BankruptcyProceedingsCaseNumber
Case No. 23-90291

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
ncminc-20230330_pre.xml Edgar Link unprocessable
0001377630-23-000073-index-headers.html Edgar Link pending
0001377630-23-000073-index.html Edgar Link pending
0001377630-23-000073.txt Edgar Link pending
0001377630-23-000073-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ncminc-20230330.htm Edgar Link pending
ncminc-20230330.xsd Edgar Link pending
ncminc-20230330_g1.jpg Edgar Link pending
ncminc-20230330_cal.xml Edgar Link unprocessable
ncminc-20230330_def.xml Edgar Link unprocessable
ncminc-20230330_lab.xml Edgar Link unprocessable
ncminc-20230330_htm.xml Edgar Link completed
q1202310-qncmiexhibit311.htm Edgar Link pending
q1202310-qncmiexhibit312.htm Edgar Link pending
q1202310-qncmiexhibit321.htm Edgar Link pending
q1202310-qncmiexhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending